Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Heterocyclic Compounds >  6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester

6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester

Basic information Safety Supplier Related

6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester Basic information

Product Name:
6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester
Synonyms:
  • 6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester
  • 6,8-Dibromoimidazo[1,2-a]pyrazine-ethyl-2-carboxylate
  • Ethyl 6,8-dibromoimidazo[1,2-a]pyrazine-2-carboxylate
  • Imidazo[1,2-a]pyrazine-2-carboxylic acid, 6,8-dibromo-, ethyl ester
CAS:
87597-21-5
MF:
C9H7Br2N3O2
MW:
348.98
Mol File:
87597-21-5.mol
More
Less

6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester Chemical Properties

Density 
2.06±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-3.87±0.30(Predicted)
Appearance
Off-white to light yellow Solid
More
Less

6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester Usage And Synthesis

Synthesis

70-23-5

24241-18-7

87597-21-5

Step A: Preparation of ethyl 6,8-dibromoimidazo[1,2-a]pyrazine-2-carboxylate At room temperature, 2-amino-3,5-dibromopyrazine (20 g, 79 mmol) was dissolved in dimethyl carbonate (133 mL) and stirred until completely dissolved. Subsequently, ethyl 3-bromo-2-oxopropionate (17.14 g, 79 mmol) was added to the reaction system in one go. The reaction mixture was heated to 110 °C with continuous stirring for 3 hours. Upon completion of the reaction, the mixture was cooled to room temperature and stirring was continued overnight. Water and dichloromethane (DCM) were added to the reaction mixture, the aqueous phase was separated and extracted with DCM. The organic phases were combined, washed with water, dried over anhydrous sodium sulfate (Na2SO4), filtered and the solvent evaporated. Purification by fast column chromatography afforded 13.95 g (50.6% yield) of ethyl 6,8-dibromoimidazo[1,2-a]pyrazine-2-carboxylate, the target compound. The product was characterized by 1H-NMR (300 MHz, CDCl3): δ= 8.30 (s, 1H), 8.27 (s, 1H), 4.48 (q, 2H), 1.43 (t, 3H) ppm.

References

[1] Patent: WO2012/80232, 2012, A1. Location in patent: Page/Page column 36-37
[2] Patent: WO2012/80228, 2012, A1. Location in patent: Page/Page column 42-43
[3] Patent: WO2012/80234, 2012, A1. Location in patent: Page/Page column 45
[4] Patent: WO2012/80236, 2012, A1. Location in patent: Page/Page column 64
[5] Patent: US2013/281460, 2013, A1. Location in patent: Paragraph 0270-0271

6,8-Dibromo-imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl esterSupplier

Fuzhou Fukang Pharmaceutical Technology Co., Ltd. Gold
Tel
18150835816
Email
120023275@qq.com
QINGDAO CARELONGPHARMATECH CO.,LTD
Tel
0532-0532-88191853 13061484198
Email
sales@carelongchem.com
Changzhou Wanyao Biotechnology Co., Ltd.
Tel
0519-89185693 15312551983
Email
2410037592@qq.com
Shanghai Keepontech Co.,Ltd
Tel
021-54849683 13601642561
Email
sales@keepontech.com
ShangHai KenEn Chemical Technology Co., Ltd.
Tel
13120367189
Email
mychess007@163.com